Your browser is no longer supported. Please, upgrade your browser.
ALLK [NASD]
Allakos Inc.
Index- P/E- EPS (ttm)-3.10 Insider Own1.30% Shs Outstand51.51M Perf Week-4.97%
Market Cap5.21B Forward P/E- EPS next Y-4.59 Insider Trans-44.13% Shs Float47.08M Perf Month-5.10%
Income-153.50M PEG- EPS next Q-0.88 Inst Own95.40% Short Float6.80% Perf Quarter-35.51%
Sales- P/S- EPS this Y-64.20% Inst Trans-5.29% Short Ratio15.06 Perf Half Y-0.18%
Book/sh12.70 P/B7.80 EPS next Y-17.60% ROA-28.80% Target Price135.88 Perf Year32.08%
Cash/sh12.54 P/C7.90 EPS next 5Y-10.50% ROE-30.80% 52W Range62.21 - 157.98 Perf YTD-29.22%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-36.52% Beta-
Dividend %- Quick Ratio29.80 Sales past 5Y- Gross Margin- 52W Low61.20% ATR5.31
Employees125 Current Ratio29.80 Sales Q/Q- Oper. Margin- RSI (14)40.96 Volatility7.11% 4.87%
OptionableYes Debt/Eq0.00 EPS Q/Q-70.00% Profit Margin- Rel Volume0.54 Prev Close99.09
ShortableYes LT Debt/Eq0.00 EarningsMay 10 AMC Payout- Avg Volume212.50K Price100.28
Recom2.10 SMA20-4.94% SMA50-9.74% SMA200-5.71% Volume79,941 Change1.20%
Feb-24-21Initiated Cantor Fitzgerald Overweight $218
Jan-15-21Initiated BofA Securities Buy $145
Dec-21-20Initiated SVB Leerink Outperform $150
Feb-27-20Initiated Barclays Underweight $36
Feb-04-20Resumed Goldman Neutral $89 → $94
Aug-13-18Initiated William Blair Outperform
Aug-13-18Initiated Jefferies Buy $53
Aug-13-18Initiated Goldman Neutral $31
May-10-21 04:01PM  
Apr-19-21 04:01PM  
Mar-30-21 08:00AM  
Mar-01-21 08:00AM  
Feb-17-21 02:22AM  
Jan-13-21 11:16PM  
Jan-06-21 11:16AM  
Dec-22-20 04:05PM  
Dec-21-20 10:07AM  
Dec-10-20 10:33PM  
Nov-09-20 08:01AM  
Nov-02-20 08:00AM  
Oct-28-20 08:20PM  
07:41AM  
Oct-27-20 07:56PM  
04:09PM  
Oct-26-20 07:00AM  
07:00AM  
Oct-21-20 05:00PM  
Aug-28-20 06:53AM  
Aug-10-20 08:00AM  
Jul-18-20 09:55AM  
Jul-05-20 03:31PM  
Jun-16-20 06:30PM  
Jun-03-20 08:01AM  
May-21-20 08:01AM  
May-15-20 09:02AM  
May-14-20 12:00PM  
May-11-20 12:40PM  
10:31AM  
10:03AM  
08:01AM  
08:00AM  
May-10-20 07:20PM  
05:10PM  
02:11PM  
01:45PM  
01:30PM  
May-09-20 02:43PM  
12:22PM  
12:00PM  
07:20AM  
May-08-20 04:00PM  
01:55PM  
01:30PM  
01:23PM  
12:00PM  
10:55AM  
09:38AM  
May-07-20 06:35PM  
02:15PM  
01:00PM  
11:12AM  
10:18AM  
09:27AM  
May-06-20 05:00PM  
04:50PM  
01:27PM  
10:12AM  
09:41AM  
May-05-20 05:10PM  
04:10PM  
09:17AM  
09:00AM  
May-04-20 03:45PM  
01:26PM  
09:29AM  
09:24AM  
08:01AM  
May-03-20 05:16PM  
02:25PM  
01:50PM  
09:50AM  
May-01-20 02:15PM  
01:05PM  
09:56AM  
Apr-30-20 06:23PM  
06:05PM  
Apr-29-20 08:00PM  
06:30PM  
03:01PM  
11:00AM  
09:45AM  
Apr-28-20 09:30PM  
04:34PM  
Apr-27-20 06:35PM  
12:45PM  
Apr-26-20 01:34AM  
Apr-25-20 09:29AM  
Apr-23-20 05:25PM  
03:30PM  
Apr-22-20 07:28PM  
04:28PM  
10:20AM  
Apr-21-20 08:01AM  
Apr-20-20 12:15PM  
Apr-18-20 06:08PM  
Apr-17-20 05:45PM  
Apr-16-20 08:03AM  
Apr-15-20 07:30PM  
Allakos Inc. operates as a clinical stage biopharmaceutical company. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and/or eosinophilic duodenitis; and a Phase II/III study for the treatment of eosinophilic esophagitis. The is also developing lirentelimab (AK002) for the treatment of mast cell gastrointestinal disease, severe allergic conjunctivitis, chronic urticaria, and indolent systemic mastocytosis. Allakos Inc. was incorporated in 2012 and is headquartered in Redwood City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Tomasi AdamPresident, COO and CFOApr 14Option Exercise0.6920,00013,750173,126Apr 14 08:00 PM
Tomasi AdamPresident, COO and CFOApr 14Sale107.7720,0002,155,400153,126Apr 14 08:00 PM
Tomasi AdamPresident, COO and CFOApr 13Option Exercise0.6920,00013,750173,126Apr 14 08:00 PM
Tomasi AdamPresident, COO and CFOApr 13Sale103.0820,0002,061,600153,126Apr 14 08:00 PM
Tomasi AdamPresident, COO and CFOApr 12Option Exercise0.6920,00013,750173,126Apr 14 08:00 PM
Tomasi AdamPresident, COO and CFOApr 12Sale104.4020,0002,088,000153,126Apr 14 08:00 PM
RASMUSSEN HENRIK S MDChief Medical OfficerApr 06Option Exercise1.1610,00011,625111,819Apr 06 08:00 PM
RASMUSSEN HENRIK S MDChief Medical OfficerApr 06Sale111.6810,0001,116,800101,819Apr 06 08:00 PM
RASMUSSEN HENRIK S MDChief Medical OfficerApr 05Option Exercise1.1620,00023,250121,819Apr 06 08:00 PM
RASMUSSEN HENRIK S MDChief Medical OfficerApr 05Sale113.0620,0002,261,200101,819Apr 06 08:00 PM
RASMUSSEN HENRIK S MDChief Medical OfficerApr 01Option Exercise1.1620,00023,250121,819Apr 06 08:00 PM
RASMUSSEN HENRIK S MDChief Medical OfficerApr 01Sale114.4020,0002,288,000101,819Apr 06 08:00 PM
MCKEARN JOHN PDirectorMar 26Sale115.007,439855,4851,200Mar 30 09:18 PM
JANNEY DANIELDirectorMar 26Sale115.1717,3081,993,29356,293Mar 30 06:27 PM
JANNEY DANIELDirectorMar 22Sale119.7013,1481,573,79073,601Mar 24 07:21 PM
Alexander RobertChief Executive OfficerMar 17Option Exercise0.6920,00013,750265,395Mar 17 08:00 PM
Alexander RobertChief Executive OfficerMar 17Sale121.1420,0002,422,800245,395Mar 17 08:00 PM
James Steven PDirectorMar 16Option Exercise0.533,5001,8383,500Mar 17 08:00 PM
Alexander RobertChief Executive OfficerMar 16Option Exercise0.6920,00013,750265,395Mar 17 08:00 PM
Alexander RobertChief Executive OfficerMar 16Sale121.7620,0002,435,200245,395Mar 17 08:00 PM
James Steven PDirectorMar 16Sale121.653,500425,7750Mar 17 08:00 PM
Alexander RobertChief Executive OfficerMar 15Option Exercise0.6920,00013,750265,395Mar 17 08:00 PM
Alexander RobertChief Executive OfficerMar 15Sale122.7820,0002,455,600245,395Mar 17 08:00 PM
JANNEY DANIELDirectorMar 15Sale124.566,708835,54886,749Mar 16 04:17 PM
JANNEY DANIELDirectorMar 12Sale124.184,071505,53793,457Mar 16 04:17 PM
JANNEY DANIELDirectorMar 11Sale124.626,006748,46897,528Mar 11 07:35 PM
Hudson Peter Amember - potential 10% groupMar 11Sale123.9220,2472,509,1058,000Mar 11 07:28 PM
Tomasi AdamPresident, COO and CFOMar 10Option Exercise0.6920,00013,750173,126Mar 10 08:00 PM
Hudson Peter Amember - potential 10% groupMar 10Sale124.372,107262,04828,247Mar 11 07:28 PM
Tomasi AdamPresident, COO and CFOMar 10Sale121.7820,0002,435,600153,126Mar 10 08:00 PM
Tomasi AdamPresident, COO and CFOMar 09Option Exercise0.6920,00013,750173,126Mar 10 08:00 PM
Tomasi AdamPresident, COO and CFOMar 09Sale121.7820,0002,435,600153,126Mar 10 08:00 PM
JANNEY DANIELDirectorMar 09Sale125.0010012,500103,534Mar 11 07:35 PM
Hudson Peter Amember - potential 10% groupMar 09Sale124.752,200274,44630,354Mar 11 07:28 PM
Tomasi AdamPresident, COO and CFOMar 08Option Exercise0.6920,00013,750173,126Mar 10 08:00 PM
Tomasi AdamPresident, COO and CFOMar 08Sale122.7820,0002,455,600153,126Mar 10 08:00 PM
MORE ROBERT Jmember - potential 10% groupMar 05Sale117.7812,6761,493,0400Mar 05 07:42 PM
MORE ROBERT Jmember - potential 10% groupMar 04Sale111.5515,0001,673,18412,676Mar 05 07:42 PM
NOHRA GUY P10% OwnerMar 04Sale111.6425,7682,876,7420Mar 08 08:40 PM
RASMUSSEN HENRIK S MDChief Medical OfficerMar 03Option Exercise1.1620,00023,250123,771Mar 03 09:55 PM
MORE ROBERT Jmember - potential 10% groupMar 03Sale113.184,878552,09427,676Mar 05 07:42 PM
Tomasi AdamPresident, COO and CFOMar 03Sale113.563,189362,143153,126Mar 03 09:59 PM
RASMUSSEN HENRIK S MDChief Medical OfficerMar 03Sale112.9821,9522,480,244101,819Mar 03 09:55 PM
RASMUSSEN HENRIK S MDChief Medical OfficerMar 02Option Exercise1.1620,00023,250125,087Mar 03 09:55 PM
RASMUSSEN HENRIK S MDChief Medical OfficerMar 02Sale117.3220,0002,346,400105,087Mar 03 09:55 PM
RASMUSSEN HENRIK S MDChief Medical OfficerMar 01Option Exercise1.1620,00023,250125,087Mar 03 09:55 PM
RASMUSSEN HENRIK S MDChief Medical OfficerMar 01Sale120.6620,0002,413,200105,087Mar 03 09:55 PM
Walker Paul EdwardDirectorDec 31Sale140.4635,0234,919,3782,163,260Jan 04 05:51 PM
Walker Paul EdwardDirectorDec 30Sale141.7168,3929,691,8532,198,283Jan 04 05:51 PM
Tomasi AdamPresident, COO and CFODec 29Option Exercise4.315,41623,356157,757Dec 31 09:04 PM
Alexander RobertChief Executive OfficerDec 29Option Exercise4.318,24035,535241,105Dec 31 09:03 PM
NOHRA GUY P10% OwnerJun 17Sale75.627,692581,6930Jun 19 07:24 PM
MORE ROBERT Jmember - potential 10% groupMay 18Sale71.5811,538825,9390May 20 06:08 PM
Hudson Peter Amember - potential 10% groupMay 18Sale71.8611,538829,0850May 20 06:07 PM